Commodore Capital L.P., 10% Owner at Enliven Therapeutics, Inc. (ELVN), bought 730,512 shares at $22.07 ($14K) on 2023-02-23, disclosed to the SEC on 2023-02-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 729,891 | $0 | 0.0% |
| 2 | $22.07 | 621 | $14K | 100.0% |
| Total | $0.02 avg | 730,512 | $14K | 100% |
| Filing → |
| VERA | BUY | 2023-06-22 | $13.6M | — | Filing → |
| IMRA | BUY | 2023-02-23 | $284K | — | Filing → |
| STSA | SELL | 2022-11-16 | $2.3M | — | Filing → |